The ASGPR has unique and very high selectivity for GalNAc and is highly endocytic upon engagement, making it an ideal molecule to target in order to promote exclusive uptake and internalization of siRNA molecules within the liver to correct metabolic disorders (Nair et al., 2014). The gene discussed is ASGR1; the disease is metabolic disease.